ID   M21L22
AC   CVCL_JZ14
SY   M21-L22; M21-L variant 12
DR   cancercelllines; CVCL_JZ14
DR   Wikidata; Q54903522
RX   PubMed=1376331;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JZ12 ! M21L
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
RX   PubMed=1376331; DOI=10.1172/JCI115811; PMCID=PMC295910;
RA   Felding-Habermann B., Mueller B.M., Romerdahl C.A., Cheresh D.A.;
RT   "Involvement of integrin alpha V gene expression in human melanoma
RT   tumorigenicity.";
RL   J. Clin. Invest. 89:2018-2022(1992).
//